Delivery Order SPE2DB25D3012-SPE2DB25FWYRM
- Not listed
- The Defense Logistics Agency awarded a $1,241.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL, 200 mL unit). This competitive award, which carries an ultimate completion date of December 31, 2025, represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's distribution facility in...
- The Defense Logistics Agency awarded a $1,154.95 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml) pharmaceutical product, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $2,477.82 delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml), a local anesthetic pharmaceutical product. This firm fixed price contract, with an ultimate completion date of June 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml quantities, with a firm fixed price ceiling value of $1,908.72. The contract, which is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $4,400.42 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) in 200 mL units at a firm fixed price of $4,058.09. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The work is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units) at a ceiling value of $1,431.54. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is performed out of the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL, 200 mL units) with a ceiling value of $5,149.90. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.5% (150 mg/30 ml) on November 7, 2025, with a ceiling value of $3,164.35 and ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $5,150.36 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL in 200 mL units). This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of December 31, 2025. The product will be performed and delivered from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYRMDelivery Order
This delivery order, valued at $1,004.61, was awarded to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml quantities. The Defense Logistics Agency, under the Department of Defense, funded this non-set-aside, competitively awarded contract with a firm fixed price structure and an ultimate completion date of July 18, 2025. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This award represents a child delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally. The current delivery order for this local anesthetic agent reflects the company's role as a critical vendor within the Defense Health Agency's pharmaceutical supply chain, providing both brand-name and generic medications to support military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/17/25 |